140 related articles for article (PubMed ID: 24707726)
1. [Pseudogene PTENP1 5'-region methylation in endometrial cancer and hyperplasias].
Kovalenko TF; Sorokina AV; Ozolinia LA; Patrushev LI
Bioorg Khim; 2013; 39(4):445-53. PubMed ID: 24707726
[TBL] [Abstract][Full Text] [Related]
2. The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females.
Kovalenko TF; Morozova KV; Ozolinya LA; Lapina IA; Patrushev LI
Acta Naturae; 2018; 10(1):43-50. PubMed ID: 29713518
[TBL] [Abstract][Full Text] [Related]
3. Expression of
Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the PTENP1 pseudogene as potential epigenetic marker of age-related changes in human endometrium.
Kovalenko TF; Morozova KV; Pavlyukov MS; Anufrieva KS; Bobrov MY; Gamisoniya AM; Ozolinya LA; Dobrokhotova YE; Shakhparonov MI; Patrushev LI
PLoS One; 2021; 16(1):e0243093. PubMed ID: 33481830
[TBL] [Abstract][Full Text] [Related]
5. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?
Ioffe YJ; Chiappinelli KB; Mutch DG; Zighelboim I; Goodfellow PJ
Gynecol Oncol; 2012 Feb; 124(2):340-6. PubMed ID: 22005521
[TBL] [Abstract][Full Text] [Related]
6. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
7. PTEN regulates expression of its pseudogene in glioblastoma cells in DNA methylation-dependent manner.
Kovalenko TF; Yadav B; Anufrieva KS; Larionova TD; Aksinina TE; Latyshev YA; Bastola S; Shakhparonov MI; Pandey AK; Pavlyukov MS
Biochimie; 2024 Apr; 219():74-83. PubMed ID: 37619809
[TBL] [Abstract][Full Text] [Related]
8. Considerations when analyzing the methylation status of PTEN tumor suppressor gene.
Zysman MA; Chapman WB; Bapat B
Am J Pathol; 2002 Mar; 160(3):795-800. PubMed ID: 11891178
[TBL] [Abstract][Full Text] [Related]
9. Pseudogene PTENP1 Suppresses Gastric Cancer Progression by Modulating PTEN.
Guo X; Deng L; Deng K; Wang H; Shan T; Zhou H; Liang Z; Xia J; Li C
Anticancer Agents Med Chem; 2016; 16(4):456-64. PubMed ID: 25968876
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer.
Zhang R; Guo Y; Ma Z; Ma G; Xue Q; Li F; Liu L
Oncotarget; 2017 Apr; 8(16):26079-26089. PubMed ID: 28212532
[TBL] [Abstract][Full Text] [Related]
11. Studying the Oncosuppressive Functions of PTENP1 as a ceRNA.
Travis G; Haddadi N; Simpson AM; Marsh DJ; McGowan EM; Nassif NT
Methods Mol Biol; 2021; 2324():165-185. PubMed ID: 34165715
[TBL] [Abstract][Full Text] [Related]
12. Divergent Activity of the Pseudogene
Yndestad S; Austreid E; Skaftnesmo KO; Lønning PE; Eikesdal HP
Mol Cancer Res; 2018 Jan; 16(1):78-89. PubMed ID: 29021233
[TBL] [Abstract][Full Text] [Related]
13. PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma.
Gao L; Ren W; Zhang L; Li S; Kong X; Zhang H; Dong J; Cai G; Jin C; Zheng D; Zhi K
Mol Carcinog; 2017 Apr; 56(4):1322-1334. PubMed ID: 27862321
[TBL] [Abstract][Full Text] [Related]
14.
Khatami F; Shahriari S; Aminimoghaddam S; Klashami ZN; Farahani MS; Teimoori-Toolabi L; Amoli MM; Asadi M; Rashidi BH
Epigenomics; 2023 Apr; 15(8):507-516. PubMed ID: 37345350
[No Abstract] [Full Text] [Related]
15. [Study on expression of PTEN gene and its pseudogene PTENP1 in acute leukemia and correlation between them].
Wang CC; Huai L; Zhang CP; Jia YJ; Li QH; Chen YR; Tian Z; Tang KJ; Xing HY; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):896-901. PubMed ID: 23363743
[TBL] [Abstract][Full Text] [Related]
16. Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
Kerwin J; Khan I;
Elife; 2020 Apr; 9():. PubMed ID: 32314732
[TBL] [Abstract][Full Text] [Related]
17. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
19. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
[TBL] [Abstract][Full Text] [Related]
20. Pseudogene PTENP1 Functions as a Competing Endogenous RNA (ceRNA) to Regulate PTEN Expression by Sponging miR-499-5p.
Wang L; Zhang N; Wang Z; Ai DM; Cao ZY; Pan HP
Biochemistry (Mosc); 2016 Jul; 81(7):739-47. PubMed ID: 27449620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
